Efficacy and safety of varlitinib, a reversible pan-HER tyrosine kinase inhibitor, in combination with platinum-based regimens in biliary tract cancers: A pooled analysis from three phase I studies.

varlitinib (ASLAN001) - ASLAN

gemcitabine - generics

capecitabine - generics

fluorouracil - generics

cisplatin - generics

oxaliplatin - generics

https://meetinglibrary.asco.org/record/168652

Aaron C. Tan; Do-Youn Oh; Yee Chao; Chih-Yi Hsieh; Wei-Ling Chang; Fenny Isanto; Ying-Chen Chen; Mark McHale; Bertil Lindmark; Matthew C.H. Ng

Jan 15, 2019